{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:57:31Z","timestamp":1791104251900,"version":"4.1.0"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,2]],"date-time":"2012-04-02T00:00:00Z","timestamp":1333324800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0034138","type":"journal-article","created":{"date-parts":[[2012,4,2]],"date-time":"2012-04-02T21:03:23Z","timestamp":1333400603000},"page":"e34138","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":81,"title":["Treatment with a Substance P Receptor Antagonist Is Neuroprotective in the Intrastriatal 6-Hydroxydopamine Model of Early Parkinson's Disease"],"prefix":"10.1371","volume":"7","author":[{"given":"Emma","family":"Thornton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Vink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,4,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00415-008-5004-3","article-title":"Epidemiology of Parkinson's disease.","volume":"255","author":"G Alves","year":"2008","journal-title":"J Neurol"},{"key":"ref2","first-page":"1","article-title":"Neurokinin peptides and neurokinin receptors as potential therapeutic intervention targets of basal ganglia in the prevention and treatment of Parkinson's disease.","volume":"5","author":"L-W Chen","year":"2004","journal-title":"Current Drug Targets"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1111\/j.1460-9568.2003.03014.x","article-title":"Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease.","volume":"18","author":"AM Depino","year":"2003","journal-title":"Eur J Neurosci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinson's disease.","volume":"23","author":"PL McGeer","year":"2008","journal-title":"Mov Disord"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cnr.2006.09.006","article-title":"Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.","volume":"6","author":"RL Mosley","year":"2006","journal-title":"Clin Neurosci Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00702-007-0790-9","article-title":"Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice.","volume":"114","author":"S Takagi","year":"2007","journal-title":"J Neural Transm"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5483\/BMBRep.2010.43.4.225","article-title":"The role of neuroinflammation on the pathogenesis of Parkinson's disease.","volume":"43","author":"YC Chung","year":"2010","journal-title":"BMB Rep"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00702-008-0030-y","article-title":"Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA.","volume":"115","author":"AL Bartels","year":"2008","journal-title":"J Neural Transm"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.20369","article-title":"Blood-brain barrier dysfunction in parkinsonian midbrain in vivo.","volume":"57","author":"R Kortekaas","year":"2005","journal-title":"Ann Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1080\/00207450802330561","article-title":"Self-amplification of nigral degeneration in Parkinson's disease: a hypothesis.","volume":"118","author":"ID Ionov","year":"2008","journal-title":"Int J Neurosci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/j.1471-4159.2007.04567.x","article-title":"Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons.","volume":"101","author":"I Rite","year":"2007","journal-title":"J Neurochem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1357-2725(01)00031-0","article-title":"Review: Substance P.","volume":"33","author":"S Harrison","year":"2001","journal-title":"The International J Biochem Cell Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.neures.2006.11.002","article-title":"Neurokinin-1 and neurokinin-3 receptors in primate substantia nigra.","volume":"57","author":"M Levesque","year":"2007","journal-title":"Neurosci Res"},{"key":"ref14","first-page":"293","article-title":"Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.","volume":"82","author":"MS Reid","year":"1990","journal-title":"Exp Brain Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neulet.2010.06.057","article-title":"A substance P mediated pathway contributes to 6-hydroxydopamine induced cell death.","volume":"481","author":"E Thornton","year":"2010","journal-title":"Neurosci Lett"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0196-9781(98)00177-6","article-title":"Subgroups of parkinsonian patients differentiated by pertidergic immunostaining of caudate nuclues biopsies.","volume":"20","author":"ML De Ceballos","year":"1999","journal-title":"Peptides"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-8993(83)90403-1","article-title":"Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains.","volume":"268","author":"A Mauborgne","year":"1983","journal-title":"Brain Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0306-4522(94)00606-6","article-title":"Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease.","volume":"66","author":"AP Nisbet","year":"1995","journal-title":"Neuroscience"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0143-4179(91)90148-C","article-title":"Dopamine dependent decrease in enkephalin and substance P levels in basal ganglia regions of postmortem Parkinsonian brains.","volume":"18","author":"SP Sivam","year":"1991","journal-title":"Neuropeptides"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0006-8993(84)90217-8","article-title":"Substance P immunoreactivity in the post-mortem parkinsonian brain.","volume":"303","author":"O Tenovuo","year":"1984","journal-title":"Brain Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0306-4522(94)90061-2","article-title":"Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of Parkinson's disease patients.","volume":"61","author":"A Fernandez","year":"1994","journal-title":"Neuroscience"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0006-8993(95)00791-N","article-title":"Neurokinin-3 receptors modulate dopamine cell function and alter the effects of 6-hydroxydopamine.","volume":"695","author":"MJ Bannon","year":"1995","journal-title":"Brain Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0301-0082(96)00015-9","article-title":"Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae.","volume":"49","author":"RK Schwarting","year":"1996","journal-title":"Prog Neurobiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exnr.2002.7891","article-title":"Modeling Parkinson's disease in rats: an evaulation of 6-OHDA lesions of the nigrostriatal pathway.","volume":"175","author":"R Deumens","year":"2002","journal-title":"Exp Neurol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0306-4522(96)00377-6","article-title":"The substantia nigra as a site of synaptic integration of functionally diverse information arising from the ventral pallidum and the globus pallidus in the rat.","volume":"75","author":"MD Bevan","year":"1996","journal-title":"Neuroscience"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00001756-199512000-00074","article-title":"Reactive astrocytes express substance-P immunoreactivity in the adult forebrain after injury.","volume":"7","author":"RC Lin","year":"1995","journal-title":"Neuroreport"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.npep.2003.12.003","article-title":"Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats.","volume":"38","author":"AJ Nimmo","year":"2004","journal-title":"Neuropeptides"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nurt.2009.10.018","article-title":"Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injury.","volume":"7","author":"R Vink","year":"2010","journal-title":"Neurotherapeutics"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.brainres.2011.03.066","article-title":"A substance P antagonist improves outcome when administered 4 hours after onset of reversible cerebral ischemia.","volume":"1393","author":"RJ Turner","year":"2011","journal-title":"Brain Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/jcbfm.2009.63","article-title":"Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury.","volume":"29","author":"JJ Donkin","year":"2009","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref31","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.","volume":"119","author":"V Brochard","year":"2009","journal-title":"J Clin Invest"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/glia.20677","article-title":"Differential neutrophil infiltration contributes to regional differences in brain inflammation in the substantia nigra pars compacta and cortex.","volume":"56","author":"KA Ji","year":"2008","journal-title":"Glia"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cnr.2006.09.004","article-title":"The cellular response in neuroinflammation: The role of leukocytes, microglia and astroctyes in neuronal death and survival.","volume":"6","author":"MJ Carson","year":"2006","journal-title":"Clin Neurosci Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1046\/j.1471-4159.2002.00928.x","article-title":"Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease.","volume":"81","author":"HM Gao","year":"2002","journal-title":"J Neurochem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00441-004-0944-0","article-title":"Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation.","volume":"318","author":"P Teismann","year":"2004","journal-title":"Cell Tissue Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.035048","article-title":"Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention.","volume":"304","author":"B Liu","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11481-006-9012-8","article-title":"Microglia as a pharmacological target in infectious and inflammatory diseases of the brain.","volume":"1","author":"RB Rock","year":"2006","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.mito.2004.07.028","article-title":"Mitochondrial dysfunction and possible treatments in Parkinson's disease-a review.","volume":"4","author":"CW Shults","year":"2004","journal-title":"Mitochondrion"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease.","volume":"65","author":"D Blum","year":"2001","journal-title":"Prog Neurobiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.4049\/jimmunol.180.12.8241","article-title":"Neurogenic exacerbation of microglial and astrocyte responses to Neisseria meningitidis and Borrelia burgdorferi.","volume":"180","author":"VS Chauhan","year":"2008","journal-title":"J Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.2741\/1377","article-title":"The role of tachykinins in central nervous system inflammatory responses.","volume":"9","author":"I Marriott","year":"2004","journal-title":"Front Biosci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1096\/fj.05-4553com","article-title":"Potent regulation of microglia-derived oxidative stress and dopaminergic neuron survival: substance P vs. dynorphin.","volume":"20","author":"ML Block","year":"2006","journal-title":"Faseb J"},{"key":"ref43","first-page":"311","article-title":"Microglial cells in neurodegenerative disorders.","volume":"43","author":"M Wojtera","year":"2005","journal-title":"Folia Neuropathol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1073\/pnas.86.13.5193","article-title":"Substance P receptor binding sites are expressed by glia in vivo after neuronal injury.","volume":"86","author":"PW Mantyh","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1523\/JNEUROSCI.5480-05.2006","article-title":"Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide.","volume":"26","author":"S Brahmachari","year":"2006","journal-title":"J Neurosci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"II58","DOI":"10.1007\/PL00007762","article-title":"Glial cells and Parkinson's disease.","volume":"247","author":"EC Hirsch","year":"2000","journal-title":"J Neurol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1002\/ana.410440726","article-title":"Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection.","volume":"44","author":"MC Rodriguez","year":"1998","journal-title":"Ann Neurol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1096\/fasebj.6.15.1464368","article-title":"Mechanisms of excitotoxicity in neurologic disease.","volume":"6","author":"MF Beal","year":"1992","journal-title":"Faseb J"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1471-4159.2005.03015.x","article-title":"Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoiong neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.","volume":"93","author":"M Marti","year":"2005","journal-title":"J Neurochem"},{"key":"ref50","article-title":"The Rat Brain Stereotaxic Coordinates","author":"G Paxinos","year":"1998"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainres.2004.07.039","article-title":"Intranigral antagonism of neurokinin 1 and 3 receptors reduces intrastriatal dopamine D1 receptor-stimulated locomotion in the rat.","volume":"1023","author":"C Bishop","year":"2004","journal-title":"Brain Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0091-3057(95)00010-T","article-title":"Effects of centrally administered neuropeptides on discriminative stimulus properties of cocaine in the rat.","volume":"51","author":"M Ukai","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0306-4522(95)00571-4","article-title":"Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat.","volume":"72","author":"CS Lee","year":"1996","journal-title":"Neuroscience"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.neures.2004.12.006","article-title":"Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.","volume":"51","author":"T Ogura","year":"2005","journal-title":"Neurosci Res"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/neu.1994.11.187","article-title":"The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury.","volume":"11","author":"RJ Hamm","year":"1994","journal-title":"J Neurotrauma"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/PAI.0b013e31821fc8cd","article-title":"Automatic non-subjective estimation of antigen content visualused by immunohistochemistry using colour deconvolution.","volume":"20","author":"SC Helps","year":"2012","journal-title":"Appl Immunohistochem Molec Morph"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0034138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T22:30:32Z","timestamp":1588977032000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0034138"}},"subtitle":[],"editor":[{"given":"Michelle L.","family":"Block","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,2]]},"references-count":56,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0034138","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,2]]}}}